bmiSMART Announces Results of Recently Published Scientific Study

SALT LAKE CITY, March 15, 2016 /PRNewswire/ -- A randomized, double-blind, placebo controlled study (published in Enliven: Journal of Dietetics and Nutrition) reports that Litramine™, the patented ingredient in bmiSMART I-REMOVE™, has been demonstrated to produce "significantly more" weight loss than a placebo group.

Logo - http://photos.prnewswire.com/prnh/20160315/344366LOGO

Not only did the placebo group not lose weight, they actually gained weight.

I-REMOVE has been scientifically developed to remove fat from the digestive process. The Litramine in I-REMOVE binds fat into molecules too large to be absorbed, thus optimizing the Weight Wellness benefits of a reduced fat diet.

The introduction to the study of Litramine published by Enliven states:

Since 1980, worldwide obesity has more than doubled with an estimated 10% of world population classified as obese [1]. It is projected that by 2048, all American adults will become overweight or obese based on 2012 trends [1]. In 2010, overweight and obesity were estimated to cause 3.4 million deaths worldwide [2]. This epidemic has also placed higher burdens on healthcare systems, as those who are obese are at higher risk for many serious health conditions…. [3].

While the study evidenced that Litramine produced weight-loss benefits without behavioral modification, the researchers counseled:

…we recommend the intake of the product in combination with a slightly hypocaloric dietary regimen, similar to the conditions applied in the previous clinical trial to achieve a better weight loss effect.

Which is precisely the bmiSMART approach to Mindful Weight Wellness: Eat healthy meals, exercise, be mindful of calories, and make I-REMOVE the last course of any meal high in dietary fat.

The additional products of the bmiSMART Weight Wellness Group—I-BLOCK™ (for reduced carb and sugar calorie absorption) and I-CONTROL™ (for reduced appetite and between-meal cravings) — also have been scientifically tested for effectiveness in double-blind placebo-controlled trials.

In fact, the bmiSMART ingredients are so effective that they have been the number one weight loss solution in Europe for the past four years.  And now they are available for the first time in the US from bmiSMART.

All three products are available for purchase at www.bmiSMART.com.

1. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al. (2014) Global, regional and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384: 766-781.
2. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, et al. (2012) A Comparative risk assessment of burden of disease and injury attributable to 67 risks factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2224-2260.
3. World Health Organisation (2015) Fact sheet no.311: Obesity and Overweight.

For more information contact:
Clifton H. Jolley, Ph.D.
Email
(214) 497-0084

SOURCE bmiSMART

Related Links

http://www.bmiSMART.com